C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) A61K 51/08 (2006.01) C07K 16/22 (2006.01) C07K 16/30 (2006.01) C07K 16/32 (2006.01) C07K 16/46 (2006.01) C12N 15/62 (2006.01) A61K 43/00 (1990.01)
Patent
CA 2129663
Disclosed is a single-chain Fv (sFv) polypeptide defining a binding site which exhibits the immunological binding propert- ies of an immunoglobulin molecule which binds c-erbB-2 or a c-erbB-2-related tumor antigen, the sFv includes at least two poly- peptide domains connected by a polypeptide linker spanning the distance between the C-terminus of one domain and the N- terminus of the other, the amino acid sequence of each of the polypeptide domains includes a set of complementarity determining regions (CDRs) interposed between a set of framework regions (FRs), the CDRs conferring immunological binding to the c-erbB- 2 or c-erbB-2-related tumor antigen.
Houston L. L.
Huston James S.
Oppermann Hermann
Ring David B.
Borden Ladner Gervais Llp
Cetus Oncology Corporation
Creative Biomolecules Inc.
Curis Inc.
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Biosynthetic binding protein for cancer marker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biosynthetic binding protein for cancer marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biosynthetic binding protein for cancer marker will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1355511